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Phenotypic Reversion of Fair Hair upon Gene
Therapy of the Phenylketonuria Mice
Beat Tho¨ny,1 Zhaobing Ding,1,* Alexandre Rebuffat,1 and Hiu Man Viecelli1
FIG. 1. Phenotypic reversion from brown to black coat color of treated phenylketonuria (PKU) (Pah-enu2) mouse (see
text for details).
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Phenylketonuria (PKU) (OMIM261600) is an autoso-mal recessive genetic disorder characterized by accu-
mulation of the essential amino acid L-phenylalanine (L-Phe)
in the body caused by deficiency of the hepatic enzyme
phenylalanine hydroxylase (PAH; EC 1.14.16.1). Owing to
attenuated biosynthesis of melanin due to systemic elevated
L-Phe, hypopigmentation is one of the visible phenotypes of
PKU. Such a phenotype can also be observed in PKU mice
bearing the homozygous Pah-enu2 allele, where it was re-
ported that restoration of hypopigmentation needs at least 5%
of the PAH enzyme activity (Fang et al., 1994; Nagasaki
et al., 1999; Viecelli et al., 2014). This phenotype was re-
versed in black 6 (C57Bl/6) PKU mice to wild-type level
after hydrodynamic tail vein injection of a recombinant non-
viral minicircle-based naked DNA vector expressing the
murine Pah-cDNA from a liver-specific promoter. Young
adult C57Bl/6 untreated wild-type and PKU mice carrying
homozygously the Pah-enu2 allele are shown in Figure 1
before (middle), and 6 weeks after infusion of the minicircle
vector MC.PKU20 (Viecelli et al., 2014). Fair-haired PKU
mice started to darken after gene transfer and eventually
became indistinguishable from wild-type. Changes from
brown to black hair persisted from then on in minicircle
vector–treated mice. Normalization of blood L-Phe con-
comitant with reversion of hypopigmentation in a dose-
dependent manner can also be observed with other gene
therapeutic vectors such as, for instance, after treatment of
PKU with AAV2 serotype 8 (rAAV2/8-PKU5) to target liver
or with rAAV2/1-mediated intramuscular expression of a
complete L-Phe hydroxylating system (Ding et al., 2006,
2008).
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